Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...

The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in ...

The Michael Jon Barlin Pediatric Lupus Research program provides funding for research projects that have the potential to ...

From subtle rashes to sun-safety strategies, Drs Maureen McMahon and John Edminister discuss how to recognize cutaneous lupus and protect patients from UV-triggered flares.

The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab ...

Lupus, an autoimmune disorder, presents skin manifestations like the butterfly rash, often mimicked by conditions such as ...

Serum S100A8/A9 levels are “significantly higher’ among patients with cognitive impairment in systemic lupus erythematosus, and changes in S100A8/A9 correspond to changes in cognition over 1 year, ...

The lupus rash is not only a visible symptom but is also closely linked to the underlying systemic activity of lupus,” said Jan Klatt, Head of Development Unit Neurology & Immunology for the ...

Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the global Phase 2 WILLOW study (NCT05162586) evaluating enpatoran, an ...

Medically reviewed by Stella Bard, MD Lupus is a chronic autoimmune disease in which your immune system mistakenly attacks ...

More than 40% of patients with systemic lupus erythematosus in a large international study reported insufficient levels of physical activity, with low activity levels correlated to worsening of ...